Summary

US Gene Expression Analysis Market is valued at approximately USD XX million in 2023 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2024-2032. Gene expression analysis is the study of the activity of genes in a cell or tissue at a given moment. It involves measuring the levels of messenger RNA (mRNA) produced from each gene, as mRNA is the intermediate molecule between DNA and protein synthesis. This process provides insights into which genes are being actively transcribed and can give clues about the functional state of cells or tissues under different conditions. Moreover, the key trend of Gene Expression Analysis Market in growing demand for personalized medicine. Gene expression analysis plays a crucial role in personalized medicine by providing insights into individual variations in gene expression profiles. This information can be used to tailor treatment strategies and improve patient outcomes in areas such as cancer therapy and precision medicine.

Gene expression analysis is widely used in pharmaceutical research and development processes, including target identification, validation, and biomarker discovery. As the pharmaceutical industry seeks to accelerate the drug development pipeline and improve the success rate of clinical trials, there is a growing demand for advanced gene expression analysis technologies and services. Additionally, other factors that support the market growth of Gene Expression Analysis Market are the rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions, cohesive government initiatives and funding, increasing adoption of precision medicine, growing research in biomarker discovery, and expansion of biotechnology and life sciences industry. However, a scarcity of experienced labor and the high cost of the instruments are likely to stymie market expansion over the projection period 2024-2032.

Major market player included in this report are:
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories Inc
Agilent Technologies Inc
Standard BioTools
Zymo Research Corporation
Company 6
Company 7
Company 8
Company 9
Company 10

The detailed segments and sub-segment of the market are explained below:

By Technology
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Microarrays
Others

By Product Type
Instruments
Reagents and Consumables
Services

By End-user
Drug Discovery & Development
Diagnostic Laboratories
Academic Research Centers


Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

ページTOPに戻る

Table of Contents

Chapter 1. US Gene Expression Analysis Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. US Gene Expression Analysis Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Technology
2.2.2. By Product Type
2.2.3. By End-User
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
Chapter 3. US Gene Expression Analysis Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. US Gene Expression Analysis Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. US Gene Expression Analysis Market Size & Forecasts by Technology 2022-2032
5.1. Polymerase Chain Reaction (PCR)
5.2. Next Generation Sequencing (NGS)
5.3. Microarrays
5.4. Others
Chapter 6. US Gene Expression Analysis Market Size & Forecasts by Product Type 2022-2032
6.1. Instruments
6.2. Reagents and Consumables
6.3. Services
Chapter 7. US Gene Expression Analysis Market Size & Forecasts by End-User 2022-2032
7.1. Drug Discovery & Development
7.2. Diagnostic Laboratories
7.3. Academic Research Centers
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Thermo Fisher Scientific Inc
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Bio-Rad Laboratories Inc
8.3.3. Agilent Technologies Inc
8.3.4. Standard BioTools
8.3.5. Zymo Research Corporation
8.3.6. Company 6
8.3.7. Company 7
8.3.8. Company 8
8.3.9. Company 9
8.3.10. Company 10
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes